ReviewFrontiers in immunology2023

Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress.

Matteo Perrino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.